Invasive candidiasis.
Lass-Flörl C, Kanj SS, Govender NP, Thompson GR 3rd, Ostrosky-Zeichner L, Govrins MA.
Nat Rev Dis Primers. 2024 Mar 21;10(1):20. doi: 10.1038/s41572-024-00503-3.
Candidemia and Invasive Candidiasis.
McCarty TP, White CM, Pappas PG.
Infect Dis Clin North Am. 2021 Jun;35(2):389-413. doi: 10.1016/j.idc.2021.03.007.
Chronic Disseminated Candidiasis in Children and the Role of Corticosteroids Therapy.
Al Yazidi LS, Elsidig N, Wali Y, Nazir H.
Pediatr Infect Dis J. 2023 May 1;42(5):e146-e151. doi: 10.1097/INF.0000000000003859. Epub 2023 Feb 16.
Candida albicans biofilms and polymicrobial interactions.
Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP.
Crit Rev Microbiol. 2021 Feb;47(1):91-111. doi: 10.1080/1040841X.2020.1843400. Epub 2021 Jan 22.
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.
Soriano A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, Pagotto A, Gonçalves-Bradley DC, Verweij PE.
J Antimicrob Chemother. 2023 Jul 5;78(7):1569-1585. doi: 10.1093/jac/dkad139.
Disseminated candidiasis.
SCHABERG A, HILDES JA, WILT JC.
AMA Arch Intern Med. 1955 Jan;95(1):112-7. doi: 10.1001/archinte.1955.00250070128015.
Treatment of invasive candidiasis in the era of Candida resistance.
Paiva JA, Pereira JM.
Curr Opin Crit Care. 2023 Oct 1;29(5):457-462. doi: 10.1097/MCC.0000000000001077. Epub 2023 Jul 28.
Rezafungin: First Approval.
Syed YY.
Drugs. 2023 Jun;83(9):833-840. doi: 10.1007/s40265-023-01891-8.
Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
Azim A, Ahmed A.
Front Cell Infect Microbiol. 2024 Mar 5;14:1256158. doi: 10.3389/fcimb.2024.1256158. eCollection 2024.
Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis.
Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP.
Infect Dis Clin North Am. 2000 Sep;14(3):721-39. doi: 10.1016/s0891-5520(05)70128-8.
